Compare IZM & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IZM | MBAI |
|---|---|---|
| Founded | 2011 | 2004 |
| Country | China | Israel |
| Employees | N/A | 85 |
| Industry | Consumer Electronics/Video Chains | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3M | 12.0M |
| IPO Year | 2021 | N/A |
| Metric | IZM | MBAI |
|---|---|---|
| Price | $0.48 | $1.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 46.6K |
| Earning Date | 10-24-2025 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.37 | $1.31 |
| 52 Week High | $2.74 | $3.92 |
| Indicator | IZM | MBAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.92 | 49.29 |
| Support Level | $0.37 | $1.38 |
| Resistance Level | $2.69 | $1.89 |
| Average True Range (ATR) | 0.13 | 0.16 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 16.15 | 29.28 |
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.